McDermott International on the successful implementation of its restructuring via parallel restructuring processes across three jurisdictions (England, the Netherlands and the U.S). The restructuring resulted in the amendment and extension of $2.6 billion of secured debt and the extinguishment of $2 billion of litigation and arbitration liabilities.
Lenders under the US$1.5 billion term loan facility of Byju’s, an Indian educational technology company which at its peak was valued at US$22 billion and had over 150 million registered students. Kirkland led a complex global enforcement and litigation strategy which to date involved multiple litigation and insolvency proceedings in India at all levels including NCLT, NCLAT, Civil Court, Commercial Court and Supreme Court, voluntary and involuntary Chapter 11 proceedings in Delaware, litigation proceedings in Miami, Delaware and New York and Singapore receivership process.
A London-based mining focused private equity firm in a Commercial Court dispute against the purchaser of two of its portfolio mines in Brazil following the termination of a US$1 billion transaction.
Pfizer, Warner-Lambert and Viatris in the “most complex follow-on damages inquiry ever heard before the Patents Court” against the Department of Health, NHS bodies and generics companies arising from cross-undertakings in damages given during the substantive patent litigation in respect of the blockbuster pain medicine Lyrica (pregabalin). [2021] EWHC 2182; [2023] EWCA Civ 166; etc. (Named one of the “Top 20 Cases of 2023” by The Lawyer.)
Pfizer in relation to UK patent litigation to clear the way for the launch of a major new bispecific antibody cancer treatment.
Intel in defence of patent infringement proceedings brought against the fully integrated voltage regulator technology employed in many of Intel’s modern processor products.
Advanced Bionics in its multi-jurisdictional revocation and infringement proceedings against MED-EL in relation to its cochlear implant technology.
A Norwegian robotics firm in patent infringement proceedings in the Unified Patent Court (UPC) in relation to order fulfilment technologies and services.
Pfizer, Warner-Lambert and Viatris in a complex damages inquiry against the Department of Health, NHS bodies and generics companies arising from cross-undertakings in damages given during the substantive patent litigation in respect of the blockbuster pain medicine Lyrica.
Norwegian robotics firm in patent infringement proceedings in the Unified Patent Court (UPC) in relation to order fulfilment technologies and services.
Teva Pharmaceutical Industries in relation to pan-European successful patent revocation proceedings concerning Factor Xa medicine Eliquis (apixaban).*
A commercial property client in relation to the successful defence of a trademark claim for infringement and passing off.*
A UK government entity on procurement of Pfizer-BioNTech COVID-19 vaccine supply contracts.*
*Prior to joining Kirkland
